SCHEMBL710252

SCHEMBL710252

O=[N+]([O-])c1cc2c3ccccc3ccc2c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 4/20 1.00
ALDH1A1 P00352 3/20 0.58
TDP1 Q9NUW8 3/20 0.56
TSHR P16473 3/20 0.56
CASP6 P55212 1/20 0.50
HNF4A P41235 1/20 0.50
CTSB P07858 2/20 0.49
CYP3A4 P08684 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CYP2A6 P11509 1/20 0.44
HSD17B10 Q99714 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878647 1.00 HPRT1 (1.00) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL29450700 1.00 HPRT1 (1.00) HPRT1ALDH1A1TDP1TSHRCASP6
Charcoal, Activated SCHEMBL5052441 0.98 HPRT1 (0.96) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL8006489 0.91 HPRT1 (0.82) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL6245129 0.88 HPRT1 (0.78) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL1556587 0.87 ALDH1A1 (0.78) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL29789001 0.87 ALDH1A1 (0.78) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL31677740 0.87 ALDH1A1 (0.78) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL8622947 0.86 HPRT1 (0.76) HPRT1ALDH1A1TDP1TSHRCASP6
SCHEMBL2627610 0.83 HPRT1 (0.71) HPRT1ALDH1A1TDP1TSHRCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12516014-B2 Photoresist composition including a chrysene compound, method of forming a pattern using the same, and method of fabricating 6-nitrochrysene SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-01-06 US claimed
US-20230357123-A1 PHOTORESIST COMPOSITION INCLUDING A CHRYSENE COMPOUND, METHOD OF FORMING A PATTERN USING THE SAME, AND METHOD OF FABRICATING 6-NITROCHRYSENE SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2023-11-09 US claimed
US-20220214283-A1 METHOD FOR IDENTIFYING GENERATION SOURCES OF FINE PARTICULATES IN ATMOSPHERE SHIMADZU CORPORATION (JP) 2022-07-07 US claimed
CN-113960220-B Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood 生态环境部华南环境科学研究所 2022-03-04 CN claimed
CN-113960220-A Synchronous detection method and application of polycyclic aromatic hydrocarbon and derivatives thereof in blood 生态环境部华南环境科学研究所 2022-01-21 CN claimed
WO-2020217543-A1 METHOD FOR IDENTIFYING GENERATION SOURCES OF FINE PARTICULATES IN ATMOSPHERE 早川 和一 2020-10-29 WO claimed
US-20180256617-A1 METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES LONGEVICA THERAPEUTICS INC. 2018-09-13 US claimed
WO-2016168670-A2 METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES LONGEVICA THERAPEUTICS INC. (US) 2016-10-20 WO claimed
EP-2948532-A1 COMPOSITION FOR REDUCING POLYNUCLEAR AROMATIC HYDROCARBON EMISSIONS KiOR, Inc. (US) 2015-12-02 EP claimed
US-9051525-B2 Composition for reducing polynuclear aromatic hydrocarbon emissions KIOR, INC. (US) 2015-06-09 US claimed
US-20140209049-A1 COMPOSITION FOR REDUCING POLYNUCLEAR AROMATIC HYDROCARBON EMISSIONS KIOR, INC. (US) 2014-07-31 US claimed
WO-2014116307-A1 COMPOSITION FOR REDUCING POLYNUCLEAR AROMATIC HYDROCARBON EMISSIONS KIOR, INC. (US) 2014-07-31 WO claimed
US-20110015149-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS CHIMERIX, INC. 2011-01-20 US claimed
US-7732534-B2 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2010-06-08 US claimed
US-20080051552-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION 2008-02-28 US claimed
US-20080051519-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2008-02-28 US claimed
EP-4750287-A1 THIN FILM-MODIFIED ELECTRODE AND ORGANIC ELEMENT USING SAME Nippon Shokubai Co., Ltd. (JP) 2026-05-27 EP disclosed
US-20260082767-A1 ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, AND ORGANIC THIN FILM TRANSISTOR NIPPON HOSO KYOKAI (JP) 2026-03-19 US disclosed
EP-1127579-A2 Method for increasing bioavailability of oral pharmaceutical compositions THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-08-29 EP disclosed
WO-2000003721-A1 IMMUNOSUPPORTIVE DRUG SPARING DIET BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015149-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS ACE, CYP27A1, LIPC HPRT1 317/4885ALDH1A1 857/4885TDP1 1517/4885
US-20260082767-A1 ORGANIC THIN FILM, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, ORGANIC THIN FILM SOLAR CELL, AND ORGANIC THIN FILM TRANSISTOR L1CAM, EML4, EPCAM HPRT1 1529/4885ALDH1A1 1513/4885TDP1 3065/4885
US-20230357123-A1 PHOTORESIST COMPOSITION INCLUDING A CHRYSENE COMPOUND, METHOD OF FORMING A PATTERN USING THE SAME, AND METHOD OF FABRICATING 6-NITROCHRYSENE CRY1, NOS1, NOP56 HPRT1 228/4885ALDH1A1 2440/4885TDP1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.